Skip to content
value.today

Generation Bio Co.

Total raised
$212 M
2 rounds on record
Latest round
$111 M
Jan 2020
First round on record
Feb 2018
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Generation Bio Co.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2020$111 MNo. 2$50 to $250 million

Generation Bio Co.: Raise no. 2, Jan 2020

Investors in this round

54 investors had bought by the notice of Jan 14, 2020: 54 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 26 investors are named for Generation Bio Co. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$111 M of $111 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Geoffrey McDonough · Executive Officer, Director
  • Mark Angelino · Executive Officer
  • Thomas Graney · Executive Officer
  • Anthony Quinn · Director
  • Catherine Stehman-Breen · Director
  • Charlie Rowland · Director
  • Donald Nicholson · Director
  • Gustav Christensen · Director
  • Jason Rhodes · Director
  • Jeff Jonas · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Geoffrey McDonough, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 14, 2020. Read the notice at the SEC.

equitySEC
Feb 2018$100 MNo. 1$50 to $250 million

Generation Bio Co.: Raise no. 1, Feb 2018

Investors in this round

26 investors had bought by the notice of Mar 5, 2018: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 26 investors are named for Generation Bio Co. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$100 M of $100 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Geoff McDonoughy · Executive Officer, Director
  • Glenn Goddard · Executive Officer
  • Mark Angelino · Executive Officer
  • Anthony Quinn · Director
  • Catherine Stehman-Breen · Director
  • Donald Nicholson · Director
  • Gustav Christensen · Director
  • Jason Rhodes · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Geoff McDonough, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 5, 2018. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Generation Bio Co. chose not to state its revenue in its newest notice of a funding round (Jan 2020).

    SEC Form D · Jan 2020

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2020

That is all the official record says: Generation Bio Co. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

26 named in official filings. Open an investor to see everything it has backed.

Investors in Generation Bio Co.
InvestorKindAmountRoundRoleSource
Anthony G. QuinnPersonnot statednot statedHeld Series C preferred stock, director (Form 3, 2020)SEC Form 3
Artal Group S.A.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Artal International Management S.A.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Artal Treasury LtdCompanynot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Atlas Venture Associates Opportunity I, LLCVenture capitalnot statednot statedHeld Series A and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Atlas Venture Associates Opportunity I, L.P.Venture capitalnot statednot statedHeld Series A and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Atlas Venture Associates X, LLCVenture capitalnot statednot statedHeld Series A and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Atlas Venture Associates X, L.P.Venture capitalnot statednot statedHeld Series A and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Atlas Venture Fund X, L.P.Venture capitalnot statednot statedHeld Series A and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Atlas Venture Opportunity Fund I, L.P.Venture capitalnot statednot statedHeld Series A and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Casdin Capital, LLCFund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Catherine Stehman-BreenPersonnot statednot statedHeld Series C preferred stock, director (Form 3, 2020)SEC Form 3
Charles A. Rowland Jr.Personnot statednot statedHeld Series C preferred stock, director (Form 3, 2020)SEC Form 3
Deerfield Management Company, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Deerfield Mgmt L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Deerfield Partners, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Donald William NicholsonPersonnot statednot statedHeld Series A preferred stock, director (Form 3, 2020)SEC Form 3
Farallon Capital Management, L.L.C.Fund or asset managernot statednot statedHeld Series C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Farallon Partners L L C/caFund or asset managernot statednot statedHeld Series C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Geoff McDonoughPersonnot statednot statedHeld Series A preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
Gustav ChristensenPersonnot statednot statedHeld Series A, B and C preferred stock, director (Form 3, 2020)SEC Form 3
Invus Public Equities Advisors, LLCFund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Invus Public Equities, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.Fund or asset managernot statednot statedHeld Series C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Westend SACompanynot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Zone Healthcare Holdings, LLCOthernot statednot statedHeld Series C preferred stock, 10% owner (Form 3, 2020)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 54 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Generation Bio Co.
NameRoleNamed in
Geoffrey McDonoughExecutive officerJan 2020
Mark AngelinoExecutive officerJan 2020
Thomas GraneyExecutive officerJan 2020
Geoff McDonoughyExecutive officerMar 2018
Glenn GoddardExecutive officerMar 2018
Anthony QuinnDirectorJan 2020
Catherine Stehman-BreenDirectorJan 2020
Charlie RowlandDirectorJan 2020
Donald NicholsonDirectorJan 2020
Geoffrey McDonoughDirectorJan 2020
Gustav ChristensenDirectorJan 2020
Jason RhodesDirectorJan 2020
Jeff JonasDirectorJan 2020
Geoff McDonoughyDirectorMar 2018